Search results for: health insurance

Reading Rheum

Daniel Hal Solomon, MD, MPH; Joan M. Von Feldt, MD; | November 1, 2007

Handpicked Reviews of Contemporary Literature

National HMO Class-Action Case Settled

Staff | November 1, 2007

The latest development in the healthcare class-action settlement will affect approximately 900,000 physicians (and some major state medical societies) who may be eligible to receive compensation from the settlement – as long as they file a claim. The case has been called “historic” by those representing both physicians and insurance companies.

ACR Attends AMA House of Delegates

Staff | September 1, 2007

On Saturday, June 23, 2007, the American Medical Association (AMA) House of Delegates convened in Chicago; the meeting’s theme was advocacy. The ACR was represented by its delegate Melvin Britton, MD, and alternate delegate Gary Bryant, MD.

ACR Board Lobbies Congress

Staff | July 1, 2007

ACR Board of Directors members recently spent time in Washington, D.C., discussing rheumatology-related issues with members of Congress, including Sen. Edward M. “Ted” Kennedy (D-Mass.). The senior senator from Massachusetts is the chair of the Senate Health, Education, Labor, and Pensions Committee, which oversees health legislation that affects rheumatologists.

Medicare D-lemmas

Ann Kepler | January 1, 2007

Rheumatologists and patients report mixed experiences with the new prescription drug benefit

Rheumatology Influencers: Dr. Baca Champions Wellness for Both Patients & Physicians

Linda Childers | January 12, 2026

As it becomes increasingly difficult for private practice physicians to remain independent & physicians are burning out, Shawn Baca, MD, FACR, is working tirelessly to change healthcare policy.

RA Research Presented at ACR Convergence 2025 in Focus

Jeffrey Curtis, MD, MS, MPH | January 9, 2026

This synopsis of research into rheumatoid arthritis highlights key areas presented at ACR Convergence 2025, including strategies to delay or prevent RA, emerging mechanisms of action in RA treatment, and the growing role of AI in advancing RA research and clinical care.